I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

I-Mab will cut 27% of staff, weeks after announcing a reprioritization of its pipeline to focus on a Phase I bispecific antibody. The move will cost the Maryland-based immuno-oncology company about ...

Analysing the top 10 tech company logos, we can understand the art and science behind creating visual identities that stand out from the crowd. Most people scroll past logos like they're invisible.

“MAB has been listed on the London Stock Exchange for just over a decade. In that time, we have grown a market-leading, specialist network for mortgage advisers whilst delivering positive returns for ...

Lee Broadcast Engineering Excellence Awards. The awards are named for Carl E. Lee, a prominent Michigan broadcast engineer and station owner who was known for his innovation and recognition of ...